Literature DB >> 26010807

Xeroderma pigmentosum complementation group F: Report of a case and review of Japanese patients.

Yukari Tofuku1, Yoshimasa Nobeyama1, Ryoichi Kamide2, Shinichi Moriwaki3, Hidemi Nakagawa1.   

Abstract

Xeroderma pigmentosum (XP) is an autosomal recessive genetic disorder characterized by extraordinary sensitivity to sunlight, resulting in cutaneous malignant tumors. Among XP, XP-F presents relatively uniquely in Japanese. To clarify the characteristics of this group, we describe a case of XP-F and review Japanese cases previously reported. A 50-year-old Japanese woman was referred to us with multiple, variously sized, light- or dark-brown macules on the face and sunlight-exposed extremities. She had experienced bulla formation with approximately 10 min of sunlight exposure during her elementary school years. Her parents had been first cousins, and her mother and sister had photosensitivity. She showed no neurological or developmental abnormalities. Ultraviolet (UV) irradiation testing revealed normal levels for minimal erythema dose with UV-A and UV-B. Sensitivity to UV-C and DNA repair ability in the patient's fibroblasts were indicated between that in normal individuals and that in an XP-A patient. Complementation assay revealed that transfection of the XPF gene led most efficient DNA repair compared with the other XP genes. Therefore, the patient was diagnosed with XP-F. Twenty-three cases of Japanese patients (six males, 17 females) with XP-F have been reported, including the present case. Our review suggested a relatively high prevalence of 50% (11/22) for cutaneous malignant tumors. A significant difference was evident in the mean age at first medical consultation between patients with cutaneous malignant tumors (53.6 years) and patients without such tumors (30.8 years). This suggests that cutaneous malignant tumors could occur in the age range of 30-50 years in XP-F patients.
© 2015 Japanese Dermatological Association.

Entities:  

Keywords:  carcinogenesis; complementation group F; cutaneous malignant tumors; hypersensitivity to sunlight; xeroderma pigmentosum

Mesh:

Substances:

Year:  2015        PMID: 26010807     DOI: 10.1111/1346-8138.12942

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  2 in total

1.  Cerebellar ataxia-dominant phenotype in patients with ERCC4 mutations.

Authors:  Hiroshi Doi; Shigeru Koyano; Satoko Miyatake; Shinji Nakajima; Yuka Nakazawa; Misako Kunii; Atsuko Tomita-Katsumoto; Kayoko Oda; Yukie Yamaguchi; Ryoko Fukai; Shingo Ikeda; Rumiko Kato; Katsuhisa Ogata; Shun Kubota; Noriko Hayashi; Keita Takahashi; Mikiko Tada; Kenichi Tanaka; Mitsuko Nakashima; Yoshinori Tsurusaki; Noriko Miyake; Hirotomo Saitsu; Tomoo Ogi; Michiko Aihara; Hideyuki Takeuchi; Naomichi Matsumoto; Fumiaki Tanaka
Journal:  J Hum Genet       Date:  2018-02-05       Impact factor: 3.172

2.  Neurodegeneration as the presenting symptom in 2 adults with xeroderma pigmentosum complementation group F.

Authors:  Niraj M Shanbhag; Michael D Geschwind; John J DiGiovanna; Catherine Groden; Rena Godfrey; Matthew J Yousefzadeh; Erin A Wade; Laura J Niedernhofer; May Christine V Malicdan; Kenneth H Kraemer; William A Gahl; Camilo Toro
Journal:  Neurol Genet       Date:  2018-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.